We are live! Join us! RheumNow Daily Recap - #ACR21 https://t.co/hUqx6B2ySD via @YouTube

• https://youtu.be/iTbsi6CSgJo

Small numbers but mirrors data from TENOR and plenty to think about here. We clearly want to see sustained remission and Ax details, but very promising! Definitely on the agenda for the @RheumNow #ACR21 GCA/PMR panel on Wed am with @LCalabreseDO @Sarah_L_Mackie @RichardPAConway

@benjaminsutu @RheumNow Always steroids first, we learned that the hard way in GUSTO - but yeah, probably something after that, and TCZ is our only b/tsDMARD choice... for the time being (at #ACR21 - mavrilimumab, baricitinib, secukinumab...)

Dr. Petri noted that 1 week off of immunosuppressants is adequate for most lupus patients to mount a response. She avoided RTX during the pandemic. In pts who have had inadequate response to 2 or 3 doses of mRNA, she switches them to J&J. #ACR21 #COVI19 CH @rheumnow https://t.co/qNjmx9uTLF

TNFi + JIA = watch the skin! A nearly 3fold increase of paradoxal psoriasis in JIA patients exposed to TNFi reported in the CARRA registry w/ incidence rate the highest on children receiving adalimumab. #Abst0241 @RheumNow #ACR2021 https://t.co/uXOwV2RlGu https://t.co/8f8mvVUkV2

• Psoriasis Rate Is Increased by the Exposure to TNF Inhibition in Children with …

Treatment for VEXAS syndrome. It is steroid responsive. Avoid IL-1 inhibitors severe skin reactions at injection site, bone marrow transplant may be curative @RheumNow #ACR21 Session6S410 L Wilson, DO Cordona https://t.co/eQ1KVDiKKV

HSS Study of 136 SLE flares post-vax: 👉100 (74%) w/expected AE (headache/myalgias) 👉11 (8.1%) pts with SLE flare 👉Majority of flares were mild-mod & occurred w/in 1 week of vaccination 👉Most resolved w/in 7 days. Abst#0896 #ACR21 @rheumnow https://t.co/e6AP8PPRH2

• Systemic Lupus Erythematosus Disease Flares After SARS-CoV-2 Vaccination - ACR …

Dr. Katie Liao presented an observational study comparing SLE pts who were Ro neg (n=208) vs Ro pos (n=185). More of the (+)Ro pts had: ⬆️Adjusted mean SLEDIA >4 ⬆️Proteinuria ⬆️Neutropenia,+RF, +dsDNA, and low C3 or C4 ⬆️Discoid or malar rash #ACR21 Abst#0323 @RheumNow

Fatigue fills us with dread: common, big issue, no proven meds, non-pharm Rx hard to access. Pragmatic RCT in UK, inflamm rheum dx: usual care v CBT v exercise program (all remote delivery) Clinically meaningful benefit - now how to access? LIFT study #ACR21 ABST0462 @RheumNow https://t.co/XsSCzkbcCd

⁦@JointMD⁩ shares his thoughts on IL23, IL17, TNF inh- where/when/how we might use them. ⁦@RheumNow⁩ #acr21 https://t.co/mVw05iFPhF

• PsA Perspectives - IL-23: Dr. Eric Ruderman - YouTube

Rheumatologists and Health Professionals: Join us tonight for RheumNow's #ACR21 Daily Recap at 7pm Eastern time . Register via the Zoom link below. https://t.co/MalO30jgo1 Or visit our YouTube channel-RheumNow. https://t.co/nBUk64XBjU https://t.co/pYEFOM1Q2g

• https://bit.ly/3k8xLiw
• https://bit.ly/3wtSfXZ

Distinguishing between #preeclampsia and #lupus nephritis flare in 🤰 #SLE patients is very important because management is different. #rheumatology #medtwitter https://t.co/Dc9ohJQ75L

Blurred line btwn RA, preRA & RA prevention which makes interpretation of RCTs problematic. I’ve learned that if pt has RA not meeting criteria, some Rx ⬇️chance of RA over time-MTX, now #Abatacept but was it RA anyway AND what happens when you stop Rx? #ACR21 @RheumNow abst#0505 https://t.co/HwivsITvCQ

• Aurelie Najm on Twitter: "Provocative study in pre-RA. SC Abatacept in pat…

#ACR21 #Aging #CommunityHub @UnaMakris @SattuiSEMD @KWyshamMD Very engaging discussion on the 5 Ms of aging + how they interconnect: 👉🏻multimorbidity (⬆️ risk) 👉🏻meds (poly pharmacy) 👉🏻mentation (cognitive impairment) 👉🏻mobility and disability 👉🏻what matters most <to patient> https://t.co/mZpk3qQFgz